Koblano Therapeutics ApS
CVR 46843703 · Private limited company (ApS) · Active · Medium risk
Koblano Therapeutics ApS is a Private limited company (ApS), founded on , based in Frederiksberg. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 2.0% over the next 12 months, which is 1.4 times the average for Danish companies. CEO: Jesper Lykkesfeldt.
Bankruptcy risk for Koblano Therapeutics ApS
1.4 × the average (1.41%) · higher risk than 82% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 46843703
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (0 years)
- Address
- Nordre Fasanvej 215
2000 Frederiksberg - Municipality
- Frederiksberg
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 36k
- Auditor
- Beierholm Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 0 |
| Missing annual report | No |
| Negative equity | – |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 32 |
| Going-concern uncertainty | No |
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Jesper Lykkesfeldt | Current | |
| Board | Jesper Lykkesfeldt | Current | |
| Board | Jens Bo Rode Hansen | Current | |
| Board | Poul Henrik Bredahl Sørensen | Current | |
| Owner (33%) | Lyfe Holding ApS | Current | |
| Owner (33%) | Harryson Holding ApS | Current | |
| Owner (33%) | Poul Sorensen Biomed Consulting Corp | Current | |
| Auditor | Beierholm Godkendt Revisionspartnerselskab | Current | |
| Founder | Lyfe Holding ApS | Current | |
| Founder | Harryson Holding ApS | Current | |
| Founder | Poul Sorensen Biomed Consulting Corp | Current |
The CEOs' other companies
Jesper Lykkesfeldt – 3 other companies
- Lyfe Holding ApS Active
- RALK LEASING ApS Opløst
- Selskabet af 16. september 2026 KOMPLEMENTAR ApS Opløst
Address history (1 moves)
| Nordre Fasanvej 215, 2000 Frederiksberg | |
| c/o Jesper Lykkesfeldt, Classensgade 17, 4. th, 2100 København Ø |
Other companies at the same address
- JAGD HOLDING ApS Bankrupt
- Das & Co. ApS Active
- FS Capital ApS Active
- Furaha ApS Active
- GZR ApS Active
- Hello Nature ApS Opløst
- JUMP ApS Active
- JUMP Holding ApS Active
- JUMP Real ApS Active
- K1 Ventures ApS Active
- KHJ DATA HOLDING ApS Active
- KTL ApS Active
- Kim Plesner ApS Active
- Lille uld ApS Active
- Lyfe Holding ApS Active
- MABRO Holding ApS Active
- MAREN HOLDING ApS Active
- Max Wilhelm Holding ApS Active
- Medusa Holding ApS Active
- Mille Klink Advisory ApS Active
- Mille Kristine Klink ApS Active
- My Sisters Holding 2 ApS Fusioneret
- My Sisters Holding ApS Active
- Najsi Holding ApS Active
- OPTIMERO ApS Active
Similar companies in Frederiksberg
- AffiCon ApS Valby
- EXTITUTION ApS København Ø
- Coco Sense ApS København NV
- Everllence Denmark A/S København SV
- BioSpectre ApS København V
- Nordic Cell Therapy Group ApS København N
- FiberSure ApS København Ø
- Tasira ApS København N
- Xenogen ApS København S
- Magnalev Core ApS København SV
- Pin Joint ApS København S
- Maglya ApS København Ø
Questions and answers about Koblano Therapeutics ApS
Has Koblano Therapeutics ApS gone bankrupt?
No, Koblano Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Koblano Therapeutics ApS?
Our model estimates a bankruptcy risk of 2.0% over the next 12 months (medium risk), which is 1.4 times the average for Danish companies.
Who is the CEO of Koblano Therapeutics ApS?
Jesper Lykkesfeldt is the CEO of Koblano Therapeutics ApS.
Who is the auditor of Koblano Therapeutics ApS?
Koblano Therapeutics ApS most recently used Beierholm Godkendt Revisionspartnerselskab.
When was Koblano Therapeutics ApS founded?
Koblano Therapeutics ApS was founded on 5 October 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.